Showing 2811-2820 of 9124 results for "".
Bellafill Fills a Niche; Soolantra Targets Rosacea
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bellafill-fills-a-niche-soolantra-targets-rosacea-/18995/In this edition of DermWireTV from the editors of Practical Dermatology® magazine, a look at the approval of Bellafill (Suneva) to treat acne scars and Soolantra (Ivermectin 1%, Galderma) to treat rosacea. Plus, Benzac (Galderma) is now available OTC to treat acne, and Opdivo (Bristol-Myers Squibb)FDA Approves New Melanoma Treatment with Novel MOA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dwtv-9-11-14--iloojede/19075/Merck's Keytruda, a novel PD-1 inhibitor, is approved for advanced melanoma, and a topical mole remover is being recalled.The Big Idea: Jeanine Downie, MD on Hiring Decisions
https://practicaldermatology.com/topics/practice-management/the-big-idea-jeanine-downie-md-on-hiring-decisions/19277/Dr. Downie discusses the important considerations in hiring, including how to spot the best candidates and ensure a top-notch patient experience. Featured in "What's the Big Idea"IDAS, LBO Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/idas-lbo-laser-system-by-quantel-derma/19373/IDAS by Quantel Derma - Green Light for Mobile Power. IDAS is the powerful LBO laser system with 532 nm wavelength for vascular indications such as rosacea or telangiectasia and pigmented skin changes. Its 8 watt power make treatments very effective. Due to its robust technology, IDAS has an officiaIts Time for Congress to Repeal Medicare's SGR
https://practicaldermatology.com/topics/practice-management/its-time-for-congress-to-repeal-medicares-sgr/19394/The AMA provides data on the impact of the SGR and the cost of repeal.DWTV Extra: Remembering Dr. Robert Sidbury
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-remembering-dr-robert-sidbury/36520/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD; Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD; and Board Member Peter A. Lio, MD, FAAD, reflect on the life and career of their colleague Robert Sidbury, MD, MPH, who passed away suddenly at the age of 61.Considerations for the Use of Biologics in Children with Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37152/Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, explains the most important factors to understand when prescribing biologics for pediatric atopicScience of Skincare Summit 2024:The Latest in Exosomes
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-the-latest-in-exosomes/29450/Practical Dermatology talks with Todd Schlesinger, MD, a dermatologist and Mohs surgeon, and a member of the Editorial Board, about the latest updates in exosomes and what to expect next. This video was recorded at the Science of Skincare Summit in Austin.ISDPA: Dr. Dy on JAK Inhibitors for Alopecia Areata
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-dy-jak-inhibitors-alopecia-areata/29150/Lady Dy, MD, talks about the efficacy and safety of JAK inhibitors for treating alopecia areata at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.The Immune System’s Role in Chronic Cases of Atopic Dermatitis
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37143/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, talks about reconciling the roles of Th2, Th22, and Th17 pathways in atopic dermatitis phenotypes, espec